A Phase 1b Food Effect Study Of The First-In-Class, Oral, Selective Inhibitor Of Nuclear Export (Sine) Selinexor (Kpt-330) In Patients (Pts) With Advanced Sarcomas.Mrinal M. Gounder,Herbert H. Loong, Kjirsten Nyquist-Schultz,Stephanie Baker,Yelena Ustoyev,Lanier Tanner,Sharon Shacham,Dilara McCauley,Tami Rashal,Jean-Richard Saint-Martin,Eran Shacham,Sharon Friedlander,Sharon Tamir,Tracey Marshall,Yosef Landesman,Michael Kauffman, Sasha Rebello,Mansoor Raza Mirza,Gary K. Schwartz,Albiruni R. A. RazakJOURNAL OF CLINICAL ONCOLOGY（2014）引用 1|浏览18暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
